Search

Author/Creator Wang, Ding

2. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020)

Authors:
Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020)

Authors:
Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 401 Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 with or without immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors. (9th November 2020)

Authors:
Sharma, Manish; Dumbrava, Ecaterina Ileana; Carvajal, Richard; Catenacci, Daniel; Emens, Leisha; Hanna, Glenn; Juric, Dejan; Kang, Yoon-Koo; Lee, Jeeyun; Lee, Keun-Wook; Li, Bob; Moore, Kathleen; Pegram, Mark; Pohlmann, Paula; Rasco, Drew; Spira, Alexander; Tan, Antoinette; Wang, Ding; Ackerman, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 401 Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 with or without immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors. (9th November 2020)

Authors:
Sharma, Manish; Dumbrava, Ecaterina Ileana; Carvajal, Richard; Catenacci, Daniel; Emens, Leisha; Hanna, Glenn; Juric, Dejan; Kang, Yoon-Koo; Lee, Jeeyun; Lee, Keun-Wook; Li, Bob; Moore, Kathleen; Pegram, Mark; Pohlmann, Paula; Rasco, Drew; Spira, Alexander; Tan, Antoinette; Wang, Ding; Ackerman, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors. (10th December 2020)

Authors:
Bhadri, Vivek; Bui, Nam; Guminski, Alexander; Oneto, Jose Mejia; Murthy, Ravi; Sankhala, Kamalesh; Wayne Saville, M; Srinivasan, Sangeetha; Steffner, Robert; Subbiah, Vivek; Wang, Ding; Yee, Nathan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors. (9th November 2020)

Authors:
Bhadri, Vivek; Bui, Nam; Guminski, Alexander; Oneto, Jose Mejia; Murthy, Ravi; Sankhala, Kamalesh; Wayne Saville, M; Srinivasan, Sangeetha; Steffner, Robert; Subbiah, Vivek; Wang, Ding; Yee, Nathan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A442
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗